Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Cognitive Impairment in Brain Tumor Survivors: Emerging Evidence to Identify Associated Fall Risk

Cognitive Impairment in Brain Tumor Survivors: Emerging Evidence to Identify Associated Fall Risk Downloaded from http://journals.lww.com/rehabonc by BhDMf5ePHKbH4TTImqenVJ2toCr/9wZZjwPUWvYES9l2nY+zyylnl33NGMK6MRsx on 10/01/2020 RESEARCH ROUND-UP Cognitive Impairment in Brain Tumor Survivors: Emerging Evidence to Identify Associated Fall Risk 1 2 Sarah Kain, PT, DPT ; Earllaine Croarkin, PT, MPT 1 2 Clinical Supervisor, Maine Strong Balance Center, Scarborough, ME; and Physical Therapist, Clinical Research Center, National Institutes of Health, Bethesda, MD Cognitive impairment is a common complication for These tests assess multiple cognitive domains. The Clock those with brain tumors. It can occur from direct effects Draw Test is used to identify cognitive impairment, which of a primary brain tumor, metastatic brain tumor, and/or can lead to dementia. There are various methods for scor- 1-3 indirectly from cancer interventions. Depending on tu- ing the Clock Draw Test, one of which is described by 9 9 mor grade, up to 81% of survivors of glioma tumors who Freund et al in 2005. Freund et al use a 7-point scale to have yet to receive intervention can experience cogni- score how accurately one draws clock features. “0” points tive impairment. Cancer-related cognitive impairment in- indicate potentially poor cognitive status, while “7” in- cludes, but is not limited to, deficits in memory, reasoning, dicates excellent cognitive status. Lycke http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Rehabilitation Oncology Wolters Kluwer Health

Cognitive Impairment in Brain Tumor Survivors: Emerging Evidence to Identify Associated Fall Risk

Kain,, Sarah; Croarkin,, Earllaine
Rehabilitation Oncology , Volume 38 (3) – Jul 1, 2020
Download PDF
3 pages

Loading next page...
 
/lp/wolters-kluwer-health/cognitive-impairment-in-brain-tumor-survivors-emerging-evidence-to-C1TEcYz7gp
Publisher
Wolters Kluwer Health
Copyright
© 2020 Academy of Oncologic Physical Therapy, APTA.
ISSN
2168-3808
eISSN
2381-2427
DOI
10.1097/01.REO.0000000000000221
Publisher site
See Article on Publisher Site

Abstract

Downloaded from http://journals.lww.com/rehabonc by BhDMf5ePHKbH4TTImqenVJ2toCr/9wZZjwPUWvYES9l2nY+zyylnl33NGMK6MRsx on 10/01/2020 RESEARCH ROUND-UP Cognitive Impairment in Brain Tumor Survivors: Emerging Evidence to Identify Associated Fall Risk 1 2 Sarah Kain, PT, DPT ; Earllaine Croarkin, PT, MPT 1 2 Clinical Supervisor, Maine Strong Balance Center, Scarborough, ME; and Physical Therapist, Clinical Research Center, National Institutes of Health, Bethesda, MD Cognitive impairment is a common complication for These tests assess multiple cognitive domains. The Clock those with brain tumors. It can occur from direct effects Draw Test is used to identify cognitive impairment, which of a primary brain tumor, metastatic brain tumor, and/or can lead to dementia. There are various methods for scor- 1-3 indirectly from cancer interventions. Depending on tu- ing the Clock Draw Test, one of which is described by 9 9 mor grade, up to 81% of survivors of glioma tumors who Freund et al in 2005. Freund et al use a 7-point scale to have yet to receive intervention can experience cogni- score how accurately one draws clock features. “0” points tive impairment. Cancer-related cognitive impairment in- indicate potentially poor cognitive status, while “7” in- cludes, but is not limited to, deficits in memory, reasoning, dicates excellent cognitive status. Lycke

Journal

Rehabilitation Oncology – Wolters Kluwer Health

Published: Jul 1, 2020

References

  • Treatment of radiation-induced cognitive decline in adult brain tumor patients
    Cramer
  • Objective and subjective cognitive impairment following chemotherapy for cancer: a systematic review
    Hutchinson
  • Cognitive impairment in primary brain tumors outpatients: a prospective cross-sectional survey
    Zucchella
  • Tumor-related neurocognitive dysfunction in patients with diffuse glioma: a retrospective cohort study prior to antitumor treatment
    van Kessel
  • The Influence of Cognitive function on balance, mobility, and falls in older cancer survivors
    Blackwood
  • Mild cognitive impairment is associated with falls among older adults: findings from the Irish Longitudinal Study on Ageing (TILDA)
    Tyrovolas
  • A review of cognitive screening tools in cancer
    Isenberg-Grzeda
  • The Mini-Cog as a screen for dementia: validation in a population-based sample
    Borson
  • Drawing clocks and driving cars
    Freund
  • Validation of the Freund Clock Drawing Test as a screening tool to detect cognitive dysfunction in elderly cancer patients undergoing comprehensive geriatric assessment
    Lycke
  • Falls in hospices: a cancer network observational study of fall rates and risk factors
    Pearse
  • Neuropsychological assessment of patients undergoing surgery due to low-grade glioma involving the supplementary motor area
    Tymowski
  • Predictors of health-related quality of life in neurosurgical brain tumor patients: focus on patient-centered perspective
    Bunevicius
  • Evaluation of health-related quality of life in Lithuanian brain tumor patients using the EORTC Brain Cancer Module
    Bunevičius
  • Preoperative low tri-iodothyronine concentration is associated with worse health status and shorter five year survival of primary brain tumor patients
    Bunevičius
  • Health-related quality of life in patients with high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study
    Reijneveld
  • Surgery for high-grade gliomas in the aging
    Konglund
  • Effects of radiotherapy on cognitive function in patients with low-grade glioma measured by the Folstein Mini-Mental State Examination
    Brown
  • Use of the Freund Clock Drawing Test within the Mini-Cog as a screening tool for cognitive impairment in elderly patients with or without cancer
    Ketelaars
  • Feasibility study of the Montreal Cognitive Assessment (MoCA) in patients with brain metastases
    Olson
  • Prospective comparison of two cognitive screening tests: diagnostic accuracy and correlation with community integration and quality of life
    Olson
  • Prospective comparison of the prognostic utility of the Mini Mental State Examination and the Montreal Cognitive Assessment in patients with brain metastases
    Olson
  • Exploring the measurement properties of the Montreal Cognitive Assessment in a population of people with cancer
    Arcuri
  • Patient reported feasibility and acceptance of Montreal Cognitive Assessment (MoCA) screening pre- and postoperatively in brain tumour patients
    Renovanz
  • Cognitive screening in brain tumors: short but sensitive enough?
    Robinson
  • The High Sensitivity Cognitive Screen
    Fogel
  • Assessing cognitive function in cancer patients
    Vardy
  • Cognitive function, fatigue, and menopausal symptoms in women receiving adjuvant chemotherapy for breast cancer
    Tchen
  • Fatigue, menopausal symptoms, and cognitive function in women after adjuvant chemotherapy for breast cancer: 1- and 2-year follow-up of a prospective controlled study
    Fan
  • Cognitive function in breast cancer patients receiving adjuvant chemotherapy
    Brezden
  • Impact of androgen deprivation therapy on physical and cognitive function, as well as quality of life of patients with nonmetastatic prostate cancer
    Joly
  • The relationship between executive function and falls and gait abnormalities in older adults: a systematic review
    Kearney
  • Cognitive contributions to gait and falls: evidence and implications
    Amboni
  • The role of executive function and attention in gait
    Yogev-Seligmann
  • Exploring the roles of central and peripheral nervous system function in gait stability: preliminary insights from cancer survivors
    Monfort
  • Trail Making Test A and B: normative data stratified by age and education
    Tombaugh